ARTICLE
16 June 2020

MSRB Answers More Questions On COVID-19 Regulatory Relief

CW
Cadwalader, Wickersham & Taft LLP

Contributor

Cadwalader, established in 1792, serves a diverse client base, including many of the world's leading financial institutions, funds and corporations. With offices in the United States and Europe, Cadwalader offers legal representation in antitrust, banking, corporate finance, corporate governance, executive compensation, financial restructuring, intellectual property, litigation, mergers and acquisitions, private equity, private wealth, real estate, regulation, securitization, structured finance, tax and white collar defense.
The MSRB provided additional guidance for regulated entities concerning COVID-19-related regulatory relief.
United States Corporate/Commercial Law

The MSRB provided additional guidance for regulated entities concerning COVID-19-related regulatory relief.

The FAQs address, among other things:

  • relief from examination requirements under MSRB Rule G-3 ("Professional Qualification Requirements");
  • supervisory considerations under MSRB Rule G-27 ("Supervision");
  • transaction reporting obligations under Federal Reserve Board facilities;
  • the process for providing customers with mark-up disclosures pursuant to MSRB Rule G-15 ("Confirmation, Clearance, Settlement and Other Uniform Practice Requirements with Respect to Transactions with Customers"); and
  • best execution obligations under MSRB Rule G-18 ("Best Execution") and fair pricing obligations under MSRB Rule G-30 ("Prices and Commissions").

Primary Sources

  1. MSRB FAQ: Frequently Asked Questions Related to COVID-19 Pandemic Regulatory Relief

Originally published 11 June 2020

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More